Cite
HARVARD Citation
Rosenthal, E. et al. (2021). Corrigendum to "Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations" [Vaccine 38(51) (2020) 8206–8215]. Vaccine. 39 (36), pp. 5231-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rosenthal, E. et al. (2021). Corrigendum to "Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations" [Vaccine 38(51) (2020) 8206–8215]. Vaccine. 39 (36), pp. 5231-. [Online].